Optimizing Treatment on Idiopathic Inflammatory Myopathies
ConditionIdiopathic Inflammatory Myopathies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Sao Paulo
About this trial
As a T2T, our patients with idiopathic inflammatory myopathies will receive pulse therapies with methyprednisolone and/or human intravenous immunoglobulin, or only methyprednisolone at disease onset.
This scheme is an internal routine protocol of our Service.
Eligibility criteria
Qualifiers
Idiopathic inflammatory myopathies
Disqualifiers
Inclusion body myositis, muscular dystrophies, neoplasia-associated myopathies, overlapped myopathies, others myopathies
Trial design
Treatments tested in this trial
- Intravenous Infusion
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov